Acute Porphyria Drugs

A02BB01 - Misoprostol

Probably not porphyrinogenic
PNP

Rationale
Prostaglandin. Probably only insignificant hepatic exposure.
Chemical description
Tablets; 0.2-0.8 mg/d. Synthetic prostaglandin, which is inhibitor of ventricular secretion. Mucosaprotective effect against ASA induced ventricular lesions. Metabolized in several organs by beta-omega oxidation. Misoprostol and misoprostolic acid is excreted by the kidneys and faeces as various metabolites.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes A02B / A02BB or go back.
References
# Citation details PubMed ID
Porphyria Drug Lists
1. French List
Centre Français des Porphyries
2. South African List
Porphyria South Africa No longer maintained
Tradenames

Cytotec Cytotec Cytotec Cytotec Cytotec Cytotec · Misoprostol Cytotec Cytotec · Misofar Cytotec · Misoprostol Cytotec Cytil · Miso-Care Avren · Cyotec Nasogastric · Cytotec · Rexol Cytotec Misoprostol Cytotec Cytotec Cytotec Cytotec Cyprostol · Cytotec Misprostol
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙